Brought to you by:

Cell & Gene Therapy

Monoclonal antibody orange red background 3d rendering
Biotech

Allogene reports patient death tied to mAb in CAR-T pivotal trial

Given the patient death, the company is dropping the monoclonal antibody called ALLO-647 completely, CEO David Chang told Fierce.
Gabrielle Masson Aug 1, 2025 8:30am
Closeup of blue eye on black background

4DMT climbs as gene therapy patients keep jettisoning jabs

Aug 1, 2025 5:35am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
FDA
Favicon Fierce Pharma

Vinay Prasad departs FDA amid controversy over gene therapy

Jul 30, 2025 9:33am
Clear out clearnance rubbish scrap heap

AstraZeneca drops lead TCR therapy from $200M Neogene buy

Jul 29, 2025 4:13am
timer sand clocks time

Arrowhead meets $100M milestone, awaits Sarepta payment

Jul 28, 2025 3:10pm
More News

Cell therapy biotech keeps adapting, selling 4 programs for $55M

Jul 28, 2025 10:52am

Elevidys fallout hasn't dented Roche's hopes for gene therapies

Jul 25, 2025 8:30am
Fierce Pharma

FDA eyeing study requirements to confirm Elevidys safety: report

Jul 24, 2025 3:12pm

Galapagos builds island of cell therapies amid pipeline pruning

Jul 24, 2025 10:59am